Beyond the method change in clinical practice: evaluation of insulin-like growth factor I assay

OBJECTIVES: Insulin-like growth factor I (IGF-I) is the preferred biomarker for diagnosing and monitoring growth-related disorders but its serum quantification presents several difficulties since different IGF-I assays still leads to different IGF-I concentrations, especially when results are either...

Descripción completa

Detalles Bibliográficos
Autores principales: Sienes Bailo, Paula, Fabre Estremera, Marta, Cuenca Alcocel, José, César Márquez, María Ángeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197437/
https://www.ncbi.nlm.nih.gov/pubmed/37363432
http://dx.doi.org/10.1515/almed-2021-0069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197437/
https://www.ncbi.nlm.nih.gov/pubmed/37363432
http://dx.doi.org/10.1515/almed-2021-0069

Ejemplares similares